Comparison

(R)-(-)-JQ1 Enantiomer European Partner

Item no. HY-13030A-25mg
Manufacturer MedChem Express
CASRN 1268524-71-5
Amount 25 mg
Quantity options 100 mg 10mM/1mL 10 mg 1 g 200mg 25 mg 2 mg 500mg 50 mg 5g 5 mg
Specific against other
Purity 99.66
Citations [1]Filippakopoulos, et al. Selective inhibition of BET bromodomains. Nature. 2010 Dec 23;468(7327):1067-73.<br/>[2]Mahe M, et al. An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers. EMBO Mol Med. 2018 Apr;10(4). pii: e8163.
Smiles O=C(C[C@H]1N=C(C2=C(N3C1=NN=C3C)SC(C)=C2C)C4=CC=C(C=C4)Cl)OC(C)(C)C
Available
Product Description
(R)-(-)-JQ1 Enantiomer is the stereoisomer of (+)-JQ1. (+)-JQ1 potently decreases expression of both BRD4 target genes, whereas (R)-(-)-JQ1 Enantiomer has no effect.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
456.99
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer
Solubility
DMSO : ≥ 100 mg/mL
Target
Epigenetic Reader Domain
Manufacturers Target
Epigenetic Reader Domain
Manufacturers Pathway
Epigenetics
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close